The top eight DEGs that exhibited an increase in the SLE‐MS group and a decrease in MSCT group were HSP90AA1, KIT, GUSBP17, CDK6, BICC1, GABRE, PIK3R2, and SPINK2 (Figure 6B). This evidence concerns the gene BICC1 and myeloid sarcoma.